Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Article in English | IMSEAR | ID: sea-144792

ABSTRACT

Background & objectives: Replication of influenza A virus in the respiratory tract leads to cell damage and liberation of cytokines and chemokines. The in vivo cytokine induction and modulation by recombinant transforming growth factor- β1 (rTGF-β1) has not been studied. Therefore, in the present study the effect of rTGF-β1, a potent immunomodulatory cytokine which has anti-inflammatory properties and downregulates the release of inflammatory molecules, against influenza-virus infection in the airway of mice was investigated. Methods: rTGF-β1 was administered intravenously to mice with concomitant intranasal infection of influenza A/Udorn/317/72 (H3N2) virus, and the survival rate, virus titre, histopathological changes and levels of factors regulating inflammation in the airway fluid were analysed. Result: The immune response to influenza A virus was characterized by an influx of both macrophages and lymphocytes into the lungs of the infected host. rTGF-β1 significantly suppressed virus multiplication and improved the survival rate of mice. rTGF-β1 downregulated infiltration of neutrophils and the release of inflammatory molecules, such as interferon-gamma (IFN-γ), interleukin-1 β (IL-1β) and stimulated release of IL-10 that potentiates anti-inflammatory response into airway. Interpretation & conclusions: A generalized pulmonary inflammation does not contribute to viral clearance but represents an immunological background within which antiviral immunity operates. Treatment with rTGF-β1 reduced macrophage count and neutrophils influx in lungs of infected mice.


Subject(s)
Immune System Phenomena , Influenza A virus/growth & development , Influenza A virus/immunology , Influenza A virus/pathogenicity , Respiratory Tract Infections , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/immunology
2.
Article in English | IMSEAR | ID: sea-135829

ABSTRACT

Background & objectives: The pathogenesis of infl uenza virus infection involves virus replication in epithelial cells of the respiratory tract and the consequent degeneration of infected cells. Infl uenza virus induces cellular degeneration following infection of cultured cells in vitro, and the cytopathic effect (CPE) occurs principally through apoptotic cell death. This study was undertaken to fi nd out the effect of zinc on infl uenza virus induced apoptosis in cultured HeLa cells. Methods: The sub-confl uent monolayer HeLa cells were used to study the effect of zinc on infl uenza virus induced apoptosis. The apoptotic markers viz., caspase-3 activity, phagocytic index, morphological changes, and DNA fragmentation were assayed. Results: When HeLa cells were infected with a cell adapted pathogenic strain of infl uenza A (A/Udorn/ 317/72H3N2) virus, DNA fragmentation was observed in virus infected cells by 24 h post infection and caspase-3 activity was maximum at 4 h post infection after which it reached to plateau. Treatment of cells with 0.1 5mM concentration of zinc till 8 h post infection inhibited DNA fragmentation and also caspase 3 activity was decreased signifi cantly up to 2 h post infection. Interpretation & conclusions: When the infected HeLa cells were incubated with adherent macrophages, effi cient phagocytosis occurred and the release of virus into the culture medium was inhibited. These results suggested that inhibitory effect on infl uenza virus induced apoptotic death of cultured cells can be determined at an early stage of the infection by treatment of zinc.


Subject(s)
Analysis of Variance , Apoptosis/drug effects , Apoptosis/physiology , Caspase 3/metabolism , DNA Fragmentation/drug effects , HeLa Cells , Humans , Influenza A Virus, H3N2 Subtype/drug effects , Influenza A Virus, H3N2 Subtype/growth & development , Influenza A Virus, H3N2 Subtype/physiology , Phagocytosis , Viral Plaque Assay , Virus Replication/drug effects , Zinc/pharmacology
3.
Indian J Exp Biol ; 2006 Apr; 44(4): 265-78
Article in English | IMSEAR | ID: sea-59332

ABSTRACT

Since 1997, highly pathogenic avian influenza (HPAI) H5N1 virus crossed the species barriers from birds to humans and caused fatal disease, leading to great speculation about a possible influenza pandemic. This subtype is characterized by its pathogenicity in a large number of animal species and resistance to older class of antiviral drugs. At present, two out of three general conditions for the onset of pandemic have been met, emergence of new virus; and its ability to replicate in humans causing serious illness. Next influenza pandemic might be due to human to human transmission. This review addresses the biological and epidemiological aspects of influenza in context of India.


Subject(s)
Animals , Hemagglutinins, Viral/metabolism , Humans , India/epidemiology , Influenza A Virus, H5N1 Subtype/pathogenicity , Influenza in Birds/epidemiology , Influenza, Human/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL